Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nik Krajnc

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 22, 2025
Diagnostic accuracy of inter-eye difference of ganglion cell layer alone in identifying optic neuritis in multiple sclerosisNik Krajnc, Fabian Föttinger, Markus Ponleitner, et al.
European Journal of Neurology|November 27, 2024
Autoimmune screening panel in patients with multiple sclerosis: A Vienna multiple sclerosis database studyFabian Föttinger, Nik Krajnc, Katharina Riedl, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 16, 2026
Association of treatment decision with personality, coping strategies and impulsivity in patients with multiple sclerosisJan Philipp Nolte, Fabian Föttinger, Nik Krajnc, et al.
Clinical Chemistry and Laboratory Medicine|April 19, 2025
Impact of renal function impairment on kappa free light chain indexMartin Schmidauer, Fabian Föttinger, Klaus Berek, et al.
Journal of Neurology|November 19, 2025
Safety of disease-modifying therapies in multiple sclerosis: real-world data from the Austrian MS Treatment Registry (AMSTR)Tobias Monschein, Helena Untersteiner, Markus Ponleitner, et al.
European Journal of Neurology|April 5, 2025
Reactive Pleocytosis After Repeated Lumbar Puncture-Implications for Clinical PracticeMartin Schmidauer, Fabian Föttinger, Klaus Berek, et al.
Journal of Neurology|April 9, 2026
The role of age in choosing high-efficacy treatment for multiple sclerosis: an Austrian MS Database studyHarald Hegen, Fabian Föttinger, Janette Walde, et al.
Brain Communications|November 12, 2025
Dynamic relationship between cerebrospinal fluid immune cells and tissue damage markers in multiple sclerosisSina Zaic, Theresa König, Markus Ponleitner, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 20, 2025
Serum neurofilament light chain and glial fibrillary acidic protein levels are associated with inner retinal layer thinning in multiple sclerosisNik Krajnc, Markus Ponleitner, Fabian Föttinger, et al.
European Journal of Neurology|October 24, 2024
Treating to target in multiple sclerosis: Do we know how to measure whether we hit it?Gabriel Bsteh, Nik Krajnc, Patrick Altmann, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 22, 2025
Diagnostic accuracy of inter-eye difference of ganglion cell layer alone in identifying optic neuritis in multiple sclerosisNik Krajnc, Fabian Föttinger, Markus Ponleitner, et al.
European Journal of Neurology|November 27, 2024
Autoimmune screening panel in patients with multiple sclerosis: A Vienna multiple sclerosis database studyFabian Föttinger, Nik Krajnc, Katharina Riedl, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 16, 2026
Association of treatment decision with personality, coping strategies and impulsivity in patients with multiple sclerosisJan Philipp Nolte, Fabian Föttinger, Nik Krajnc, et al.
Clinical Chemistry and Laboratory Medicine|April 19, 2025
Impact of renal function impairment on kappa free light chain indexMartin Schmidauer, Fabian Föttinger, Klaus Berek, et al.
Journal of Neurology|November 19, 2025
Safety of disease-modifying therapies in multiple sclerosis: real-world data from the Austrian MS Treatment Registry (AMSTR)Tobias Monschein, Helena Untersteiner, Markus Ponleitner, et al.
European Journal of Neurology|April 5, 2025
Reactive Pleocytosis After Repeated Lumbar Puncture-Implications for Clinical PracticeMartin Schmidauer, Fabian Föttinger, Klaus Berek, et al.
Journal of Neurology|April 9, 2026
The role of age in choosing high-efficacy treatment for multiple sclerosis: an Austrian MS Database studyHarald Hegen, Fabian Föttinger, Janette Walde, et al.
Brain Communications|November 12, 2025
Dynamic relationship between cerebrospinal fluid immune cells and tissue damage markers in multiple sclerosisSina Zaic, Theresa König, Markus Ponleitner, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 20, 2025
Serum neurofilament light chain and glial fibrillary acidic protein levels are associated with inner retinal layer thinning in multiple sclerosisNik Krajnc, Markus Ponleitner, Fabian Föttinger, et al.
European Journal of Neurology|October 24, 2024
Treating to target in multiple sclerosis: Do we know how to measure whether we hit it?Gabriel Bsteh, Nik Krajnc, Patrick Altmann, et al.
Pageof 7